Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of DPP-4 Inhibition on BNP in Diabetic Heart Failure
NCT02312427Phase 4Completed
- Sponsor
- Mitsui Memorial Hospital
- Start
- Jan 2015
- Primary completion
- Mar 2016
- Countries
- 1
01
Overview
Phase 4, open-label trial in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Mitsui Memorial Hospital. Primary endpoint: Serum B-type Natriuretic Peptide level at 2 months. Started Jan 2015; status: completed.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02312427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02312427.